跳至主要内容
临床试验/NCT07367113
NCT07367113招募中不适用

Effect of Peripheral Perfusion Index-guided Fluid Resuscitation on the Prevention of Acute Skin Failure in Elderly Critically Ill Patients: A Prospective, Randomized, Controlled Trial

Ying Wang1 个研究点 分布在 1 个国家目标入组 216 人开始时间: 2025年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
216
试验地点
1
主要终点
Incidence of Acute Skin Failure(per the NPUAP/EPUAP 2014 Guidelines)

研究概览

简要总结

This prospective, randomized, controlled trial aimed to evaluate whether fluid resuscitation guided by the Peripheral Perfusion Index (PPI) could reduce the incidence of Acute Skin Failure (ASF) in elderly critically ill patients. A total of 216 patients aged ≥65 years with sepsis or other types of shock requiring early aggressive fluid resuscitation were enrolled and randomly assigned in a 1:1 ratio to either the PPI-guided resuscitation group or the conventional resuscitation group. The intervention group targeted maintaining PPI ≥1.4 in addition to conventional hemodynamic goals, while the control group followed standard resuscitation protocols. The primary outcome was the incidence of ASF within 7 days of ICU admission, diagnosed according to NPUAP/EPUAP (2014) criteria. Secondary outcomes included time to ASF occurrence, lactate clearance, cumulative fluid balance, organ function, and long-term prognosis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 65 years.
  • Diagnosis of sepsis (according to Sepsis-3 criteria) or other types of shock requiring early and aggressive fluid resuscitation.
  • APACHE II score ≥ 15 at ICU admission.
  • Expected ICU length of stay ≥ 72 hours.
  • Written informed consent obtained from the patient or their legally authorized representative.

排除标准

  • Pre-existing stage III or higher pressure injury or skin necrosis at the time of enrollment.
  • Severe dermatological disease or peripheral vascular disease that could interfere with the assessment of skin or peripheral perfusion.
  • Inability to perform continuous finger pulse oximetry monitoring (e.g., due to bilateral finger injury, amputation, or severe peripheral edema).
  • Contraindications to liberal fluid resuscitation (e.g., acute cardiogenic pulmonary edema, severe heart failure with fluid overload).
  • Expected survival < 24 hours due to terminal illness or irreversible condition. Concurrent participation in another interventional clinical trial.

研究组 & 干预措施

eripheral Perfusion Index-guided Fluid Resuscitation Protocol

Experimental

干预措施: Peripheral Perfusion Index-guided Fluid Resuscitation Protocol (Other)

Conventional Fluid Resuscitation Group

Active Comparator

干预措施: Conventional Goal-Directed Fluid Resuscitation (Other)

结局指标

主要结局

Incidence of Acute Skin Failure(per the NPUAP/EPUAP 2014 Guidelines)

时间窗: From ICU admission up to 7 days

Proportion of patients who develop new-onset Acute Skin Failure (ASF) within 7 days after ICU admission. ASF is diagnosed and staged according to the NPUAP/EPUAP (2014) criteria.

Incidence of Acute Skin Failure

时间窗: From ICU admission up to 7 days

Proportion of patients who develop new-onset Acute Skin Failure (ASF) within 7 days after ICU admission. ASF is diagnosed and staged according to the NPUAP/EPUAP (2014) criteria.

次要结局

  • Time to Acute Skin Failure (ASF) Onset(From ICU admission up to 7 days)
  • Maximum Stage of Acute Skin Failure(From ICU admission up to 7 days)
  • Lactate Clearance Rate at 6 Hours(Baseline and 6 hours after resuscitation initiation)
  • Lactate Clearance Rate at 24 Hours(Baseline and 24 hours after resuscitation initiation)
  • Cumulative Fluid Balance at 72 Hours(From ICU admission up to 72 hours)
  • Incidence of Acute Kidney Injury(From ICU admission up to 7 days)
  • Duration of Mechanical Ventilation(From ICU admission until ICU discharge, up to 90 days)
  • Length of ICU Stay(From ICU admission until ICU discharge, up to 90 days)
  • 28-Day All-Cause Mortality(From ICU admission up to 28 days)
  • 90-Day All-Cause Mortality(From ICU admission up to 90 days)
  • Barthel Index at Hospital Discharge(At hospital discharge, up to 90 days after ICU admission)
  • Total Hospitalization Costs(From hospital admission to hospital discharge, up to 90 days)
  • 30-Day Unplanned Readmission Rate(30 days after hospital discharge)
  • Incidence of Resuscitation-Related Serious Adverse Events(From ICU admission until ICU discharge, up to 90 days)

研究者

发起方
Ying Wang
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Ying Wang

Clinical Professor

Nantong First People's Hospital

研究点 (1)

Loading locations...

相似试验